Insmed Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	819.56	606.42	363.71	305.21	245.36	188.46
Revenue Growth (YoY)	115.09%	66.73%	19.17%	24.39%	30.19%	14.63%
Cost of Revenue	149.08	122.94	85.74	65.57	55.13	44.15
Gross Profit	670.48	483.49	277.97	239.64	190.23	144.31
Selling, General & Admin	800.88	701.17	461.12	344.5	265.78	234.27
Depreciation & Amortization Expenses	6.82	6	5.05	5.05	5.05	5.05
Research & Development	828	771.09	598.37	571.01	397.52	272.74
Other Operating Expenses	186.73	251.99	91.68	28.7	-20.8	7.33
Total Operating Expenses	1,822	1,730	1,156	949.26	647.55	519.4
Operating Income	-1,152	-1,247	-878.25	-709.63	-457.32	-375.09
Interest Income	58.79	60.66	53.31	42.13	11.08	0.17
Interest Expense	-82.31	-83.8	-84.91	-81.69	-26.45	-40.47
Other Non-Operating Income (Expense)	-2.71	-1.84	-0.21	2.18	-7.47	-21.02
Total Non-Operating Income (Expense)	-26.23	-24.98	-31.81	-37.39	-22.83	-61.32
Pretax Income	-1,178	-1,272	-910.07	-747.01	-480.15	-436.41
Provision for Income Taxes	5.58	5.03	3.71	2.56	1.38	-1.76
Net Income	-1,184	-1,277	-913.77	-749.57	-481.53	-434.65
Net Income to Common	-1,184	-1,277	-913.77	-749.57	-481.53	-434.65
Shares Outstanding (Basic)	208	199	164	140	123	112
Shares Outstanding (Diluted)	208	199	164	140	123	112
Shares Change (YoY)	20.61%	21.32%	16.81%	14.14%	9.74%	14.86%
EPS (Basic)	-5.75	-6.42	-5.57	-5.34	-3.91	-3.88
EPS (Diluted)	-5.75	-6.42	-5.57	-5.34	-3.91	-3.88
Free Cash Flow	-921.64	-967.58	-705.81	-549.54	-410.32	-370.59
Free Cash Flow Per Share	-4.44	-4.86	-4.30	-3.91	-3.33	-3.31
Gross Margin	81.81%	79.73%	76.43%	78.52%	77.53%	76.57%
Operating Margin	-140.56%	-205.59%	-241.47%	-232.51%	-186.39%	-199.03%
Profit Margin	-144.44%	-210.54%	-251.24%	-245.59%	-196.26%	-230.63%
FCF Margin	-112.45%	-159.55%	-194.06%	-180.05%	-167.23%	-196.64%
EBITDA	-1,131	-1,228	-864.53	-696.34	-445.03	-359.83
EBITDA Margin	-137.99%	-202.43%	-237.70%	-228.15%	-181.38%	-190.93%
EBIT	-1,152	-1,247	-878.25	-709.63	-457.32	-375.09
EBIT Margin	-140.56%	-205.59%	-241.47%	-232.51%	-186.39%	-199.03%
Effective Tax Rate	-0.47%	-0.40%	-0.41%	-0.34%	-0.29%	0.40%

SEC Filings: 10-K · 10-Q